Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Editorial Board125
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity107
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer93
Exploiting antifungal immunity in the clinical context79
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells72
Aging of lymphoid stromal architecture impacts immune responses66
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity54
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi54
Editorial Board50
Microbial metabolites and immunotherapy: Basic rationale and clinical indications49
Resolving inflammatory links between myocardial infarction and vascular dementia48
Pyroptosis modulation by bacterial effector proteins47
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity37
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?37
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)37
Immunity to pathogenic fungi in the eye37
Pyroptosis: A road to next-generation cancer immunotherapy36
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity36
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease35
Pyroptosis and the cellular consequences of gasdermin pores35
The noncanonical inflammasome-induced pyroptosis and septic shock34
Western diet influences on microbiome and carcinogenesis33
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment31
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets31
Introduction to the special issue: Neutrophils in the tumor microenvironment31
Immunity to fungi: Editorial overview30
Introduction to the Special Issue: Nanoparticles and immune responses30
Specialized pro-resolving mediators as modulators of immune responses29
The evolving biology of cross-presentation28
Cellular and molecular diversity in spondyloarthritis27
The paradox of aging: Aging-related shifts in T cell function and metabolism27
Adaptive NK cell response to human cytomegalovirus: Facts and open issues27
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases26
TREM2: A new player in the tumor microenvironment26
Recent developments in C3-targeted complement therapeutics24
Sialic acid and Siglec receptors in tumor immunity and immunotherapy23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy23
Antigen discovery for the development of cancer immunotherapy23
The dual role of neutrophils in cancer23
Thymus aging and immune reconstitution, progresses and challenges22
Introduction to the Special Issue: Nutrition, microbiota and immunity22
T cell control of SARS-CoV-2: When, which, and where?21
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming20
Introduction to the special issue: Complexity and diversity of immune responses in COVID-1919
Targeting the tissue-complosome for curbing inflammatory disease19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?18
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity18
Publisher's note: Welcome Prof. Guido Kroemer17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice17
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease17
T cell fate decisions during memory cell generation with aging17
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells17
0.059725999832153